Autoimmune pancreatitis: a surgical dilemma.

Autor: Saavedra-Perez D; Unidad de Cirugía Hepato-Bilio-Pancreática, Servicio de Cirugía General y Digestiva, Institut Clínic de Malalties Digestives i Metabòliques, Hospital Clínic de Barcelona, Barcelona, España. Electronic address: dsaavedr@clinic.ub.es., Vaquero EC; Servicio de Gastroenterología, Institut Clínic de Malalties Digestives i Metabòliques, Hospital Clínic de Barcelona, Barcelona, España., Ayuso JR; Servicio de Radiodiagnóstico, Centre de Diagnòstic per la Imatge, Hospital Clínic de Barcelona, Barcelona, España., Fernandez-Cruz L; Unidad de Cirugía Hepato-Bilio-Pancreática, Servicio de Cirugía General y Digestiva, Institut Clínic de Malalties Digestives i Metabòliques, Hospital Clínic de Barcelona, Barcelona, España.
Jazyk: English; Spanish; Castilian
Zdroj: Cirugia espanola [Cir Esp] 2014 Dec; Vol. 92 (10), pp. 645-53. Date of Electronic Publication: 2014 Jul 24.
DOI: 10.1016/j.ciresp.2014.01.013
Abstrakt: Autoimmune pancreatitis (AIP) is defined as a particular form of pancreatitis that often manifests as obstructive jaundice associated with a pancreatic mass or an obstructive bile duct lesion, and that has an excellent response to corticosteroid treatment. The prevalence of AIP worldwide is unknown, and it is considered as a rare entity. The clinical and radiological presentation of AIP can mimic bilio-pancreatic cancer, presenting difficulties for diagnosis and obliging the surgeon to balance decision-making between the potential risk presented by the misdiagnosis of a deadly disease against the desire to avoid unnecessary major surgery for a disease that responds effectively to corticosteroid treatment. In this review we detail the current and critical points for the diagnosis, classification and treatment for AIP, with a special emphasis on surgical series and the methods to differentiate between this pathology and bilio-pancreatic cancer.
(Copyright © 2013 AEC. Publicado por Elsevier España, S.L.U. All rights reserved.)
Databáze: MEDLINE